Unmixed Monoclonal Antibody Bevacizumab from Japan
Unmixed Monoclonal Antibody Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF) for cancer therapy. It is an unmixed immunological product, not put up in measured doses or retail packaging, and is intended for further formulation. It falls under tariff item 3002.13.00 as an antibody directly involved in the regulation of immunological processes.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the product is not mixed with other active ingredients or put up for retail sale
• Provide documentation showing the product is produced by recombinant DNA technology
• Verify if a permit is needed under the Food and Drugs Act for the importation of biological drugs